Search

everythinglearnresearchcommunity

for

Search:↓

Oral zinc sulphate is an effective and safe treatment for thallium poisoning, especially for skin and hair symptoms.

COVID-19 can cause different types of hair loss, and proper diagnosis by a specialist may be needed.

Older people tend to have higher biotin levels, which are weakly linked to certain blood components and negatively linked to triglycerides; biotin should be checked in patients with high triglycerides or medication-related skin issues, and only supplemented if deficient. Vitamin D and folate deficiencies are linked to specific skin conditions.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Oral zinc sulphate is an effective and safe treatment for thallium poisoning.

In a Tuscan pediatric clinic, 7.19% of children had hair or scalp disorders, with nonscarring alopecia being the most common.

The Turkish version of the MAIA-2 Scale is valid and reliable for patients at a dermatology clinic.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.

Low iron levels and obesity are linked to chronic hair loss in women.

Combining conventional and Chinese herbal medicine could help treat some skin and hormone-related diseases.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

MS patients often have skin issues, so regular skin checks are important.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Autologous follicular stem cells improved hair loss in 57% of patients.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

Melatonin vitamin C-based nanovesicles improved hair growth and reduced hair loss in androgenic alopecia patients.

Most patients with chronic kidney disease had skin issues like paleness and dry skin, and treating these can improve their lives.

AIDS patients often have specific skin conditions that help in early diagnosis and management.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.

Most HIV patients in the study showed skin and mucous membrane issues, with oral thrush being the most common.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.